TROP2
Clinical trials for TROP2 explained in plain language.
Never miss a new study
Get alerted when new TROP2 trials appear
Sign up with your email to follow new studies for TROP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for controlling breast cancer in the brain
Disease control Recruiting nowThis study is observing how well an existing drug called Trop-2 ADC (sacituzumab govitecan) works for breast cancer patients whose cancer has spread to the brain. Researchers will collect data from about 100 patients already receiving this drug in their normal care at multiple ho…
Matched conditions: TROP2
Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New scan could tell doctors if cancer drug is working sooner
Knowledge-focused Recruiting nowThis study is testing whether a special type of PET/CT scan can predict how well a new targeted drug works for advanced lung cancer. Researchers will give the scan to 50 patients before and during their treatment to see if early scan results match their long-term response. The go…
Matched conditions: TROP2
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC